The alternative and complementary medicine market Size is projected to expand substantially, with expectations to ascend from a valuation of USD 147.7 billion in 2023 to approximately USD 1489.4 ...
Iptacopan is an innovative, first-in-class oral small molecule that reversibly inhibits factor B—a crucial serine protease in the alternative pathway of the complement system. By targeting this point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results